Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elisabeth K. Dowling"'
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Cancer cells depend on multiple driver alterations whose oncogenic effects can be suppressed by drug combinations. Here, we provide a comprehensive resource of precision combination therapies tailored to oncogenic coalterations that are recurrent acr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6621292947776bd8e421d927dbfecf67
https://doi.org/10.1158/2159-8290.c.6549560
https://doi.org/10.1158/2159-8290.c.6549560
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Supplementary Table from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b0c3ddcfcc4c082091197c01886b3f
https://doi.org/10.1158/2159-8290.22541135
https://doi.org/10.1158/2159-8290.22541135
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Supplementary Data from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56948a7772330ad1338aa3a92fca8c28
https://doi.org/10.1158/2159-8290.22541174.v1
https://doi.org/10.1158/2159-8290.22541174.v1
Supplementary Figure from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Supplementary Figure from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405a813b47ab9906d7cce9d6694e4550
https://doi.org/10.1158/2159-8290.22541171.v1
https://doi.org/10.1158/2159-8290.22541171.v1
Autor:
Xubin Li, Elisabeth K. Dowling, Gonghong Yan, Zeynep Dereli, Behnaz Bozorgui, Parisa Imanirad, Jacob H. Elnaggar, Augustin Luna, David G. Menter, Patrick G. Pilié, Timothy A. Yap, Scott Kopetz, Chris Sander, Anil Korkut
Publikováno v:
Cancer Discov
Cancer cells depend on multiple driver alterations whose oncogenic effects can be suppressed by drug combinations. Here, we provide a comprehensive resource of precision combination therapies tailored to oncogenic coalterations that are recurrent acr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f3b05d2c92bf1e9af56518b7d437f6
https://pubmed.ncbi.nlm.nih.gov/35652221
https://pubmed.ncbi.nlm.nih.gov/35652221
Autor:
Scott Kopetz, Xubin Li, Chris Sander, Anil Korkut, David G. Menter, Augustin Luna, Gonghong Yan, Jacob H. Elnaggar, Parisa Imarinad, Elisabeth K. Dowling, Behnaz Bozorgui
Cancer cells rely on co-activation of oncogenic processes that are driven by co-occurring molecular aberrations. Combination therapies that target co-activated oncogenic processes can induce stronger and more durable responses compared to mono-therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78846f5e5ec97bf1d55dd2ed980dbc1a
https://doi.org/10.1101/2020.06.03.132514
https://doi.org/10.1101/2020.06.03.132514